One Ascent Financial Services LLC Grifols Sa Transaction History

One Ascent Financial Services LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$10.37 - $12.73 $170,068 - $208,772	-16,400 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$10.21 - $15.27 $167,444 - $250,428	16,400 New	16,400 $184,000
Q3 2021 Nov 12, 2021	SELL	$14.07 - $17.3 $213,188 - $262,129	-15,152 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$15.15 - $19.78 $58,857 - $76,845	3,885 Added 34.48%	15,152 $262,000
Q4 2020 Feb 08, 2021	SELL	$16.86 - $19.67 $211,997 - $247,330	-12,574 Reduced 52.74%	11,267 $208,000
Q4 2020 Jan 13, 2021	BUY	$16.86 - $19.67 $60,274 - $70,320	3,575 Added 17.64%	23,841 $440,000
Q3 2020 Nov 02, 2020	BUY	$15.4 - $20.16 $100,777 - $131,927	6,544 Added 47.69%	20,266 $352,000
Q2 2020 Jul 21, 2020	BUY	$18.24 - $21.45 $21,778 - $25,611	1,194 Added 9.53%	13,722 $250,000
Q1 2020 Apr 14, 2020	BUY	$16.28 - $25.63 $4,151 - $6,535	255 Added 2.08%	12,528 $252,000
Q4 2019 Feb 11, 2020	BUY	$19.57 - $23.52 $240,182 - $288,660	12,273 New	12,273 $286,000
Q3 2019 Nov 15, 2019	SELL	$19.85 - $22.76 $293,700 - $336,756	-14,796 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$17.59 - $21.1 $260,261 - $312,195	14,796 New	14,796 $312,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Financial Services LLC with notifications on news.